Article

Robust identification of shared key genomic biomarkers for diagnosis and therapies of pancreatic cancer with type-2 diabetes

2023-08-14

Abstract excerpt

<title>Abstract</title> <p>Background Pancreatic cancer (PC) and type-2 diabetes (T2D) are both complex diseases and they stimulate each other for which PC patients with T2D may reach to the severe condition quickly. So, the discovery of shared key genomic biomarkers (sKGBs), pathogenetic processes, and associated drug molecules is essential for simultaneous diagnosis and therapies. Methods Integrated robust st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4aa2365c-7e5b-59bd-b36c-35d63c9a667c
DOI: 10.21203/rs.3.rs-3246376/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Robust identification of shared key genomic biomarkers for diagnosis and therapies of pancreatic cancer with type-2 diabetesDOI 10.21203/rs.3.rs-3246376/v1Read

Integrative analyzes of biomarkers and pathways for exploration the mechanisms and targets associated with pyroptosis in type 2 diabetesSemantic proximity Read

Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indicationsSemantic proximity Read

Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integrationSemantic proximity Read

Multi-omics regulatory networks reveal the key driver genes in the development of type 2 diabetesSemantic proximity Read

Genomic analysis and filtration of novel prognostic biomarkers based on metabolic and immune subtypes in pancreatic cancerSemantic proximity Read

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerSemantic proximity Read

Gene expression profiling and protein-protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patientsSemantic proximity Read

Development and clinical validation of A Novel 9-gene prognostic biomarkers based on multi-omics in pancreatic adenocarcinomaSemantic proximity Read

Integrative bioinformatics analysis of biomarkers and pathways for exploring the mechanisms and molecular targets associated with pyroptosis in type 2 diabetes mellitusSemantic proximity Read

Integrated analysis of multi-omics data to identification of prognostic genes for pancreatic cancerSemantic proximity Read

Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancerSemantic proximity Read

Integrative analyses of bulk, single-cell and spatial transcriptomics identified diabetes mellitus-related signature as a prognostic factor in pancreatic adenocarcinomaSemantic proximity Read